Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Molecular Biology
|
July 1, 2018
Functional Genomics via CRISPR-Cas
Kyle Ford, Daniella McDonald, Prashant Mali
Scientific Reports
|
April 5, 2017
Reprogramming MHC specificity by CRISPR-Cas9-assisted cassette exchange
William Kelton, Ann Cathrin Waindok, Theresa Pesch, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Interface-guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS
Kivilcim Ozturk, Rebecca Panwala, Jeanna Sheen, et al.
Biomaterials
|
December 10, 2021
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures
Michael Hu, Xin Yi Lei, Jon D Larson, et al.
Cell Reports
|
July 5, 2024
Interface-guided phenotyping of coding variants in the transcription factor RUNX1
Kivilcim Ozturk, Rebecca Panwala, Jeanna Sheen, et al.
Cancer Research Communications
|
July 2, 2024
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, et al.
Nature Genetics
|
January 20, 2025
Author Correction: A multilineage screen identifies actionable synthetic lethal interactions in human cancers
Samson H Fong, Brent M Kuenzi, Nicole M Mattson, et al.
Nature Genetics
|
November 18, 2024
A multilineage screen identifies actionable synthetic lethal interactions in human cancers
Samson H Fong, Brent M Kuenzi, Nicole M Mattson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2021
Correction: Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for <i>GNAQ</i>-Driven Uveal Melanoma
Justine S Paradis, Monica Acosta, Robert Saddawi-Konefka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for <i>GNAQ</i>-Driven Uveal Melanoma
Justine S Paradis, Monica Acosta, Robert Saddawi-Konefka, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Molecular Biology
|
July 1, 2018
Functional Genomics via CRISPR-Cas
Kyle Ford, Daniella McDonald, Prashant Mali
Scientific Reports
|
April 5, 2017
Reprogramming MHC specificity by CRISPR-Cas9-assisted cassette exchange
William Kelton, Ann Cathrin Waindok, Theresa Pesch, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Interface-guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS
Kivilcim Ozturk, Rebecca Panwala, Jeanna Sheen, et al.
Biomaterials
|
December 10, 2021
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures
Michael Hu, Xin Yi Lei, Jon D Larson, et al.
Cell Reports
|
July 5, 2024
Interface-guided phenotyping of coding variants in the transcription factor RUNX1
Kivilcim Ozturk, Rebecca Panwala, Jeanna Sheen, et al.
Cancer Research Communications
|
July 2, 2024
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, et al.
Nature Genetics
|
January 20, 2025
Author Correction: A multilineage screen identifies actionable synthetic lethal interactions in human cancers
Samson H Fong, Brent M Kuenzi, Nicole M Mattson, et al.
Nature Genetics
|
November 18, 2024
A multilineage screen identifies actionable synthetic lethal interactions in human cancers
Samson H Fong, Brent M Kuenzi, Nicole M Mattson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2021
Correction: Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for <i>GNAQ</i>-Driven Uveal Melanoma
Justine S Paradis, Monica Acosta, Robert Saddawi-Konefka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for <i>GNAQ</i>-Driven Uveal Melanoma
Justine S Paradis, Monica Acosta, Robert Saddawi-Konefka, et al.
Page
of 2